MaxCyte Inc. | Balance Sheet

Fiscal year is January-December. All values GBP Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
461.80
2,186.30
1,636.40
9,490.60
18,733.50
11,337.20
Total Accounts Receivable
463.20
899.10
984.70
1,951.00
2,362.30
3,850.90
Inventories
438.80
603.60
736.80
1,080.10
995.70
1,761
Other Current Assets
38.90
177.00
166.00
257.70
492.20
678.20
Total Current Assets
1,402.70
3,866.00
3,523.80
12,779.30
22,583.70
17,627.20
Net Property, Plant & Equipment
109.40
151.50
140.60
227.80
626.60
1,427.40
Other Assets
-
23.70
678.50
-
-
-
Total Assets
1,512.10
4,041.20
4,342.90
13,007.10
23,210.30
19,054.60
ST Debt & Current Portion LT Debt
1,087.90
995.50
557.90
11.70
631.40
Accounts Payable
841.90
880.30
1,531.30
2,569.10
3,201.60
Other Current Liabilities
477.60
868.60
1,365.00
1,993.40
1,519.20
Total Current Liabilities
2,407.40
2,744.50
3,454.20
4,574.10
5,352.20
Long-Term Debt
36.40
2,232.10
2,864.10
4,040.10
3,087.30
Other Liabilities
-
121.00
116.00
278.90
284.20
Total Liabilities
2,443.80
5,097.60
6,434.30
8,893.10
8,723.70
Common Equity (Total)
20,438.30
29,113.00
32,810.70
4,113.90
14,486.60
Total Shareholders' Equity
931.70
1,056.40
2,091.40
4,113.90
14,486.60
Total Equity
931.70
1,056.40
2,091.40
4,113.90
14,486.60
Liabilities & Shareholders' Equity
1,512.10
4,041.20
4,342.90
13,007.10
23,210.30
Preferred Stock (Carrying Value)
19,506.50
28,056.60
30,719.30
-
-

About MaxCyte

View Profile
Address
22 Firstfield Road
Gaithersburg Maryland 20878
United States
Employees -
Website http://www.maxcyte.com
Updated 07/08/2019
MaxCyte, Inc. enages in the development and licensing of cell-engineering technologies to pharmaceutical and biotechnology companies. Its propriety cell therapy is used in drug discovery and development, and biomanufacturing. Its products include MaxCyte STX, MaxCyte VLX, and MaxCyte GT.